Preliminary Program subject to change
Medicinal Chemistry Posters
Presentation Type	Poster
Summary Statement
Synthesis of 3-beta-acyloyloxy-4,6-pregnadiene-6,20-dione derivatives as antiandrogens Elena Ramirez1, Eugene Bratoeff1, Marisa Cabeza2, Victor Perez1, David Valdez1, Alejandro Orozco1 and Alejandra Munguia1, (1)National University of Mexico City, Mexico City D.F., Mexico, (2)Metropolitan University of Mexico City-Xochimilco, Mexico City D.F., Mexico Bicyclic Hydantoins as Androgen Receptor Antagonists Weifang Shan, Aaron Balog, Mark Salvati, Donna Wei, Greg Vite, Jack Hunt, Leslie Leith, Arvind Mathur, Ricardo Attar, Jieping Geng, Cheryl Rizzo, Marco Gottardis, Robert Weinmann, Stanley Krystek and John Tokarski, Bristol-Myers Squibb Company, Princeton, NJ Reduced FAK Phosphorylation and Migration Observed in Murine Melanoma Cells after Transfection with a Kinase-defective PKC alpha Yaw Amo-Mensah1, Regina Sullivan1 and Susan A. Rotenberg2, (1)Queensborough Community College, Bayside, NY, (2)Queens College, Flushing, NY Analysis and Interpretation of DNA to Metallated and Nonmetallated Tetrapyridino Porphyrazines Melanie Bozza and Richard D. Sheardy, Seton Hall University, South Orange, NJ Template-Assembled Peptide Models of the N-Peptide Helix Bundle from HIV-1 Gp41 Weiming Xu and John W. Taylor, Rutgers University, Piscataway, NJ Discovey Of PPARa/d/g Pan-agonists: Ligand Conformational Constraint and Selectivity Daniel J. Miller, Hiroo Koyama, Joel P. Berger, Karen L. MacNaul, Thomas W. Doebber, Margaret Wu, David E. Moller and Soumya P. Sahoo, Merck Research Laboratories, Rahway, NJ Discovery and Structure-Activity Relationship of Potent CC Chemokine Receptor-3 (CCR3) Antagonists Qing Shi, Patricia K. Welch, Eric A. Wedman, Soo S. Ko and George V. De Lucca, Bristol-Myers Squibb Pharmaceutical Research Institute, Lawrenceville, NJ Synthesis and Lipid Lowering Effects of Acyl-Carnitines Kyle C. Pillitteri, Rider University, Mercerville, NJ Investigation of the effect that different drying methods have on the mechanism of theophylline release from microcrystalline cellulose beads Francis Charles Mayville Jr., Kristin Kurek and Kathryn Smith, DeSales University, Center Valley, PA Switching the configuration from L to D of P1’substituents is increasing inhibitory activity for thrombin of peptides D-Phe-Pro-D-Arg-P1’-CONH2 Cristina C. Clement and Manfred Philipp, Lehman College, City University of New York (CUNY), NYC, NY Influence of Miswak on the Binding of Polyphenols to Protein Pellicle DIna M. Alhelawe Sr., J.F.K. Memorial High School, Ocean Twp., NJ Synthesis of 3-Substituted Cyclopent[a]pyrrolo[3,4-c]carbazole-5,7-dione Analogs as Potent Cell Permeable Inhibitors of PARP-1 Allison L. Zulli, James L. Diebold, Ron Bihovsky, Edward R. Bacon, Jean Husten, Mark Ator and Robert L. Hudkins, Cephalon, Inc., West Chester, PA Developing novel inhibitors of the enoyl reductase from Mycobacterium tuberculosis (InhA): SAR studies of triclosan congeners Todd J. Sullivan1, Polina Novichenok1, James J. Truglio1, Francis Johnson1, Richard A. Slayden2 and Peter J. Tonge1, (1) Stony Brook University, Stony Brook, NY, (2)Colorado State University,, Fort Collins, CO Regio- and Stereospecific Syntheses of Syn- and Anti-1,2-Imidazolylpropylamines from the Reaction of 1,1’-Carbonyldiimidazole with Syn- and Anti-1,2-Aminoalcohols Mark J. Mulvihill, Anthony I. Nigro, Cara Cesario, Vanessa Smith, Patricia Beck and Kathryn M. Stolz, OSI Pharmaceuticals, Farmingdale, NY Potent and Selective 2,6-Disubstituted Naphthalenes as Retinoic Acid Metabolic Blocking Agents (RAMBAs) Mark J. Mulvihill1, Julie L. C. Kan1, Andrew Cooke2, Patricia Beck1, Shripad Bhagwat1, Mark Bittner2, Cara Cesario1, Carrie Ecker1, David M. Keane1, Anthony I. Nigro1, Christy Nillson2, Suzanne Russo1, Vanessa Smith1, Mary Srebernak2, Feng-Lei Sun1, Michael Vrkljan2, Shannon L. Winski2, Arlindo L. Castelhano1, David Emerson2 and Neil W. Gibson1, (1)OSI Pharmaceuticals, Farmingdale, NY, (2)OSI Pharmaceuticals, Boulder, CO

General Submissions